Use filters to refine the search results.
Results 1-3 of 3
|1-Oct-2017||RAD51 expression as a biomarker of homologous recombination deficiency in ovarian cancer||Hoppe, MM; Tan, DSP; Lim, DGZ; Karnezis, A; Huntsman, D, et al|
|28-Mar-2017||Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre study||Phelps, DL; Borley, J; Flower, K; Dina, R; Darb-Esfahani, S, et al|
|5-Feb-2017||Is there a role for epigenetic enhancement of immunomodulatory approaches to cancer treatment?||Flower, KJ; Ghaem-Maghami, S; Brown, R; Imperial College Healthcare NHS Trust- BRC Funding; Imperial College Healthcare NHS Trust- BRC Funding|